76 related articles for article (PubMed ID: 19827126)
1. Targeted radionuclide therapy in head and neck cancer.
Nestor MV
Head Neck; 2010 May; 32(5):666-78. PubMed ID: 19827126
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapies in squamous cell carcinoma of the head and neck.
Gold KA; Lee HY; Kim ES
Cancer; 2009 Mar; 115(5):922-35. PubMed ID: 19156911
[TBL] [Abstract][Full Text] [Related]
3. Emerging molecular targeted therapies in squamous cell carcinoma of the head and neck.
Gilbert J; Argiris A
Clin Adv Hematol Oncol; 2006 Aug; 4(8):611-9. PubMed ID: 17099619
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents.
Caponigro F; Milano A; Basile M; Ionna F; Iaffaioli RV
Curr Opin Oncol; 2006 May; 18(3):247-52. PubMed ID: 16552236
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for head and neck cancer: latest developments and future perspectives.
Bernier J; Bentzen SM
Curr Opin Oncol; 2006 May; 18(3):240-6. PubMed ID: 16552235
[TBL] [Abstract][Full Text] [Related]
6. Emerging drugs for head and neck cancer.
Rhee JC; Khuri FR; Shin DM
Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138
[TBL] [Abstract][Full Text] [Related]
7. Combined targeted therapies in non-small cell lung cancer: a winner strategy?
Cascone T; Gridelli C; Ciardiello F
Curr Opin Oncol; 2007 Mar; 19(2):98-102. PubMed ID: 17272980
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade.
Yigitbasi OG; Younes MN; Doan D; Jasser SA; Schiff BA; Bucana CD; Bekele BN; Fidler IJ; Myers JN
Cancer Res; 2004 Nov; 64(21):7977-84. PubMed ID: 15520205
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor directed therapy in head and neck cancer.
Choong NW; Cohen EE
Crit Rev Oncol Hematol; 2006 Jan; 57(1):25-43. PubMed ID: 16207530
[TBL] [Abstract][Full Text] [Related]
10. New perspectives in medical approach to therapy of head and neck squamous cell carcinoma.
Santarelli A; Lo Russo L; Bambini F; Campisi G; Lo Muzio L
Minerva Stomatol; 2009 Sep; 58(9):445-52. PubMed ID: 19893469
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of EGFR inhibitors in head and neck squamous cell cancer.
Astsaturov I; Cohen RB; Harari PM
Cancer Treat Res; 2008; 139():135-52. PubMed ID: 18236715
[No Abstract] [Full Text] [Related]
12. Incorporation of molecularly targeted agents in the primary treatment of squamous cell carcinomas of the head and neck.
Bernier J
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1193-208, ix. PubMed ID: 19010268
[TBL] [Abstract][Full Text] [Related]
13. Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer.
Marur S; Forastiere AA
Curr Opin Oncol; 2010 May; 22(3):206-11. PubMed ID: 20216313
[TBL] [Abstract][Full Text] [Related]
14. Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.
Maione P; Gridelli C; Troiani T; Ciardiello F
Oncologist; 2006 Mar; 11(3):274-84. PubMed ID: 16549812
[TBL] [Abstract][Full Text] [Related]
15. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms and targeting of colorectal cancer.
Vanhoefer U
Semin Oncol; 2005 Dec; 32(6 Suppl 8):7-10. PubMed ID: 16360005
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?
Raben D; Bianco C; Milas L; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):139-52. PubMed ID: 15095260
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies for diagnosis and therapy of squamous cell carcinoma of the head and neck.
Gripp FM; Quak J; Leverstein H; Schrijvers A; Gerretsen M; Brakenhoff R; Van Dongen G; Snow GB; Rapoport A
Sao Paulo Med J; 1994; 112(3):612-21. PubMed ID: 7638523
[No Abstract] [Full Text] [Related]
19. [Targeted radionuclide therapy - where should we go ?].
Kinuya S
Gan To Kagaku Ryoho; 2013 Feb; 40(2):133-8. PubMed ID: 23411948
[TBL] [Abstract][Full Text] [Related]
20. Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer.
Damiana TST; Dalm SU
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34067215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
